Open-label placebo for major depressive disorder: a pilot randomized controlled trial.
作者信息
Kelley John M, Kaptchuk Ted J, Cusin Cristina, Lipkin Samuel, Fava Maurizio
出版信息
Psychother Psychosom. 2012;81(5):312-4. doi: 10.1159/000337053. Epub 2012 Aug 1.
Abstract
摘要
相似文献
1
Open-label placebo for major depressive disorder: a pilot randomized controlled trial.开放标签安慰剂治疗重度抑郁症：一项试点随机对照试验。
Psychother Psychosom. 2012;81(5):312-4. doi: 10.1159/000337053. Epub 2012 Aug 1.
2
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.富马酸喹硫平缓释片单药维持治疗重性抑郁障碍的疗效和耐受性：一项随机、安慰剂对照试验。
Depress Anxiety. 2010 Oct;27(10):964-76. doi: 10.1002/da.20740.
3
Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.依西酞普兰治疗重度哮喘合并重性抑郁障碍：一项随机、双盲、安慰剂对照的概念验证研究。
Psychosomatics. 2012 Jan-Feb;53(1):75-80. doi: 10.1016/j.psym.2011.07.009.
4
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.抗胆碱能药物东莨菪碱的抗抑郁疗效：一项随机、安慰剂对照临床试验。
Arch Gen Psychiatry. 2006 Oct;63(10):1121-9. doi: 10.1001/archpsyc.63.10.1121.
5
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.二十碳五烯酸乙酯治疗重性抑郁障碍的双盲、随机对照试验。
J Clin Psychiatry. 2009 Dec;70(12):1636-44. doi: 10.4088/JCP.08m04603. Epub 2009 Aug 25.
6
Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.重度抑郁症中的Omega-3脂肪酸。一项初步的双盲、安慰剂对照试验。
Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71. doi: 10.1016/s0924-977x(03)00032-4.
7
St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.贯叶连翘（贯叶金丝桃）与舍曲林和安慰剂治疗重性抑郁障碍的对照：一项 26 周 RCT 的延续数据。
Pharmacopsychiatry. 2012 Nov;45(7):275-8. doi: 10.1055/s-0032-1306348. Epub 2012 May 16.
8
Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.帕金森病中的抑郁症：一项关于补充ω-3脂肪酸的双盲、随机、安慰剂对照试验研究。
J Affect Disord. 2008 Dec;111(2-3):351-9. doi: 10.1016/j.jad.2008.03.008. Epub 2008 May 15.
9
Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression.在评估单相重度抑郁症治疗效果时使用安慰剂对照组。
Biol Psychiatry. 2000 Apr 15;47(8):736-44. doi: 10.1016/s0006-3223(00)00846-5.
10
An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.度洛西汀治疗肠易激综合征合并重度抑郁症患者的开放标签试点研究。
J Clin Psychopharmacol. 2016 Dec;36(6):710-715. doi: 10.1097/JCP.0000000000000599.
引用本文的文献
1
Effects of open-label placebos across populations and outcomes: an updated systematic review and meta-analysis of randomized controlled trials.开放标签安慰剂在不同人群和结局中的效果：随机对照试验的最新系统评价与荟萃分析
Sci Rep. 2025 Aug 15;15(1):29940. doi: 10.1038/s41598-025-14895-z.
2
Predicting Placebo Responses Using EEG and Deep Convolutional Neural Networks: Correlations with Clinical Data Across Three Independent Datasets.使用脑电图和深度卷积神经网络预测安慰剂反应：与三个独立数据集的临床数据的相关性
Neuroinformatics. 2025 May 19;23(2):32. doi: 10.1007/s12021-025-09725-6.
3
Potential Impact of Choline Alphoscerate on Depressive Symptoms in Association with Insulin Resistance in Elderly Patients with Type 2 Diabetes.α-甘油磷酸胆碱对老年2型糖尿病合并胰岛素抵抗患者抑郁症状的潜在影响
J Clin Med. 2025 Feb 28;14(5):1664. doi: 10.3390/jcm14051664.
4
Open label placebo for chronic low back pain: a systematic review and meta-analysis of randomized controlled trials.开放标签安慰剂治疗慢性腰痛：随机对照试验的系统评价和荟萃分析
Pain Manag. 2025 Mar;15(3):149-160. doi: 10.1080/17581869.2025.2467025. Epub 2025 Feb 17.
5
Working with patients' treatment expectations - what we can learn from homeopathy.应对患者的治疗期望——我们能从顺势疗法中学到什么。
Front Psychol. 2024 May 27;15:1398865. doi: 10.3389/fpsyg.2024.1398865. eCollection 2024.
6
Translating knowledge on placebo and nocebo effects into clinical practice.将安慰剂和反安慰剂效应的知识转化为临床实践。
Pain Rep. 2024 Mar 25;9(2):e1142. doi: 10.1097/PR9.0000000000001142. eCollection 2024 Apr.
7
Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial.增强健康成年人急性诱导疼痛中的开放标签安慰剂效应（BOLPAP研究）：一项随机对照试验的研究方案
Front Med (Lausanne). 2024 Feb 14;11:1238878. doi: 10.3389/fmed.2024.1238878. eCollection 2024.
8
Can observational learning reinforce open-label placebo hypoalgesia?观察性学习能否增强开放性安慰剂镇痛作用？
Pain. 2024 Jul 1;165(7):1605-1612. doi: 10.1097/j.pain.0000000000003161. Epub 2024 Jan 16.
9
Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study].研究方案：评估开放式标签安慰剂治疗抗抑郁药停药症状的 N-of-1 试验联合研究 [FAB 研究]。
BMC Psychiatry. 2023 Oct 13;23(1):749. doi: 10.1186/s12888-023-05184-y.
10
Effects of an open-label placebo intervention on reactions to social exclusion in healthy adults: a randomized controlled trial.一项开放标签安慰剂干预对健康成年人社交排斥反应的影响：一项随机对照试验。
Sci Rep. 2023 Sep 16;13(1):15369. doi: 10.1038/s41598-023-42547-7.
本文引用的文献
1
Reliability and validity of the Symptoms of Depression Questionnaire (SDQ).抑郁症状问卷（SDQ）的信度和效度。
CNS Spectr. 2014 Dec;19(6):535-46. doi: 10.1017/S1092852914000406. Epub 2014 Oct 2.
2
A power primer.强力底漆。
Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
3
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.初始严重程度与抗抑郁药疗效：对提交给美国食品药品监督管理局的数据进行的荟萃分析。
PLoS Med. 2008 Feb;5(2):e45. doi: 10.1371/journal.pmed.0050045.
4
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
5
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.16项抑郁症状快速检查表（QIDS）、临床医生评定版（QIDS-C）和自我报告版（QIDS-SR）：对慢性重度抑郁症患者的心理测量学评估
Biol Psychiatry. 2003 Sep 1;54(5):573-83. doi: 10.1016/s0006-3223(02)01866-8.
6
Placebo as a treatment for depression.安慰剂作为治疗抑郁症的方法。
Neuropsychopharmacology. 1994 Jul;10(4):265-9; discussion 271-88. doi: 10.1038/npp.1994.53.
Zotero 插件